0

Imazodan

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP84243583
CAS84243-58-3
Structure
MDL NumberMFCD00867109
Molecular Weight240.26
InChI KeyVXMYWVMXSWJFCV-UHFFFAOYSA-N
Description≥99% (HPLC)
SolubilityDMSO: 50 mg/mL, clear, yellow
Assay≥99% (HPLC)
Coloryellow, powder
Size10MG
1

Effectiveness of Imazodan for Treatment of Chronic Congestive Heart Failure. The Imazodan Research Group

A D Goldberg, J Nicklas, S Goldstein

Am J Cardiol. 1991 Sep 1;68(6):631-6.

PMID: 1715125

1

Multiple Molecular Forms of Phosphodiesterase and the Regulation of Cardiac Muscle Contractility

R E Weishaar, D C Kobylarz-Singer, M M Quade, R P Steffen, H R Kaplan

J Cyclic Nucleotide Protein Phosphor Res. 1986-1987;11(7):513-27.

PMID: 2831259

1

Subclasses of Cyclic AMP Phosphodiesterase in Cardiac Muscle

R E Weishaar, D C Kobylarz-Singer, H R Kaplan

J Mol Cell Cardiol. 1987 Oct;19(10):1025-36.

PMID: 2830402

1

Subclasses of Cyclic AMP-specific Phosphodiesterase in Left Ventricular Muscle and Their Involvement in Regulating Myocardial Contractility

R E Weishaar, D C Kobylarz-Singer, R P Steffen, H R Kaplan

Circ Res. 1987 Oct;61(4):539-47.

PMID: 2820608

1

Type III Phosphodiesterase Plays a Necessary Role in the Growth-Promoting Actions of Insulin, Insulin-Like Growth factor-I, and Ha p21ras in Xenopus Laevis Oocytes

S E Sadler

Mol Endocrinol. 1991 Dec;5(12):1939-46.

PMID: 1665204

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode